Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis

Calcif Tissue Int. 1996 Nov;59(5):323-7. doi: 10.1007/s002239900134.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Clinical Trials as Topic / standards*
  • Drug Approval*
  • Drug Therapy / standards*
  • Glucocorticoids / adverse effects*
  • Humans
  • Osteoporosis / chemically induced
  • Osteoporosis / drug therapy*

Substances

  • Glucocorticoids